In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry.

An in vivo mouse cage implant system was used to determine whether leukocyte cytokine mRNA responses to implanted biomaterials were dependent on surface chemistry. Surfaces displaying various chemistries (hydrophobic, hydrophilic, anionic, and cationic) were placed into stainless steel cages and implanted subcutaneously. Semiquantitative RT-PCR analyses revealed that hydrophilic surfaces showed a decreased expression of proinflammatory cytokines, IL-6 and IL-8, and pro-wound healing cytokines, IL-10 and TGF-beta by adherent cells, and mRNA levels of the proinflammatory cytokine, IL-1beta, and the pro-wound healing cytokine IL-13 were decreased in surrounding, exudate cells. Cytokine responses by adherent and exudate cells to hydrophobic, anionic and cationic surfaces were similar and indicative of a strong inflammatory response at the earliest time point followed by a wound healing response at later time points. However, no differences in the types or levels of exudate cells for any of the surfaces or the empty cage at each of the respective time points were observed, indicating their respective biocompatibility. These studies identify hydrophilic surface chemistries as having significant effects on leukocyte cytokine responses in vivo by decreasing the expression of inflammatory and wound healing cytokines by inflammatory cells adherent to the biomaterial as well as present in the surrounding exudate.

[1]  J M Anderson,et al.  In vivo biocompatibility studies. I. The cage implant system and a biodegradable hydrogel. , 1983, Journal of biomedical materials research.

[2]  J. Anderson,et al.  In vivo biocompatibility of catheter materials. , 1988, Biomaterials.

[3]  J. Curtis,et al.  Repeated Intratracheal Challenge with Particulate Antigen Modulates Murine Lung Cytokines1 2 , 2000, The Journal of Immunology.

[4]  N. Ziats,et al.  In vitro and in vivo interactions of cells with biomaterials. , 1988, Biomaterials.

[5]  H. Radzun,et al.  Multinucleated giant cells generated in vitro. Terminally differentiated macrophages with down-regulated c-fms expression. , 1988, The American journal of pathology.

[6]  J M Anderson,et al.  In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. , 1999, Journal of biomedical materials research.

[7]  M. Grounds,et al.  Direct evidence that inflammatory multinucleate giant cells form by fusion , 1982, The Journal of pathology.

[8]  J M Anderson,et al.  Influence of biomaterial surface chemistry on the apoptosis of adherent cells. , 2001, Journal of biomedical materials research.

[9]  D. Rennick,et al.  Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells , 1988, The Journal of experimental medicine.

[10]  Y. Nakayama,et al.  Spatial regulation and surface chemistry control of monocyte/macrophage adhesion and foreign body giant cell formation by photochemically micropatterned surfaces. , 1999, Journal of biomedical materials research.

[11]  J. Anderson,et al.  Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. , 1995, The American journal of pathology.

[12]  I. Clemmensen,et al.  Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL‐8, PDGF and angiostatin in relation to vascular density of xenografts in vivo , 2000, International journal of cancer.

[13]  James M. Anderson,et al.  Biological Responses to Materials , 2001 .

[14]  M. Hobbs,et al.  Recombinant human gamma-interferon induces human monocyte polykaryon formation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Anderson,et al.  Monocyte, macrophage and foreign body giant cell interactions with molecularly engineered surfaces , 1999, Journal of materials science. Materials in medicine.

[16]  M. Huleihel,et al.  Interleukin-1 receptor antagonist is produced by sertoli cells in vitro. , 2000, Endocrinology.

[17]  J M Anderson,et al.  Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking. , 1991, Journal of biomedical materials research.

[18]  A. Hiltner,et al.  Role for interleukin-4 in foreign-body giant cell formation on a poly(etherurethane urea) in vivo. , 1995, Journal of biomedical materials research.

[19]  A. Pennings,et al.  Biocompatibility study of as-polymerized poly(L-lactide) in rats using a cage implant system. , 1995, Journal of biomedical materials research.

[20]  Takehisa Matsuda,et al.  Surface macromolecular architectural designs using photo-graft copolymerization based on photochemistry of benzyl N,N-diethyldithiocarbamate , 1996 .

[21]  J M Anderson,et al.  Adsorbed serum proteins responsible for surface dependent human macrophage behavior. , 2000, Journal of biomedical materials research.

[22]  J. Anderson,et al.  Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. , 1997, Journal of immunology.

[23]  C. Katsetos,et al.  Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice. , 2000, Virology.

[24]  S. Douglas,et al.  Induction of multinucleated giant cell formation from human blood-derived monocytes by phorbol myristate acetate in in vitro culture. , 1989, Journal of immunology.

[25]  L. Weiss,et al.  TRANSFORMATION OF MONOCYTES IN TISSUE CULTURE INTO MACROPHAGES, EPITHELIOID CELLS, AND MULTINUCLEATED GIANT CELLS , 1966, The Journal of cell biology.